In the press: Biotech Finances introduces Advanced BioDesign

Advanced BioDesign is honored in the French Journal - Biotech Finances - for the development of its first-in-class ALDH inhibitor in cancer targeted therapy. 

Advanced BioDesign has developed a molecule, the DIMATE, with a 1st application in acute myeloid leukaemia.

Read the complete article (for subscribers only) here.